Michael Duckworth - Concepedia

Author

Michael Duckworth

King's College London ORCID

Also Known As

Anthony Downs, Duckworth, Michael, Eva Domanne, M. Duckworth, Martin J Duckworth, Michael Duckworth, Michael Duckworth

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

King's College London Guy's and St Thomas' NHS Foundation Trust Manchester Academic Health Science Centre University of Manchester University of Glasgow

About

Michael Duckworth is an author at King's College London specializing in medicine, immunology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	459
2	Immunology	3	3	459
3	Autoimmune Disease	2	2	275
4	Autoimmunity	2	2	275
5	Pathology	1	1	113

Michael Duckworth

Publications

760

Citations

H-Index

Page 1

	Year	Citations
AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking Niovi Setta-Kaffetzi, Michael A. Simpson, Alexander A. Navarini, The American Journal of Human Genetics InflammationMolecular ImmunologyDisease MechanismImmunologyClinical Dermatology	2014	184
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis Nick Dand, Michael Duckworth, David Baudry, Journal of Allergy and Clinical Immunology Autoimmune DiseaseMedicineBiologic Treatment ResponseImmunologyClinical Dermatology	2018	162
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris Dorottya M. Berki, Lu Liu, Siew Eng Choon, Journal of Investigative Dermatology Autoimmune DiseaseGeneralized Pustular PsoriasisMedicineImmunodeficienciesPathogenesis	2015	113
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study Nina Wilkinson, Teresa Tsakok, Nick Dand, Journal of Investigative Dermatology	2018	82
Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling Mehreen Soomro, Michael A. Stadler, Nick Dand, Arthritis & Rheumatology	2022	44
Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis Teresa Tsakok, Nina Wilson, Nick Dand, JAMA Dermatology	2019	41
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis Konstantinos Douroudis, Ravi Ramessur, Inês A. Barbosa, Journal of Investigative Dermatology	2021	30
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets Nick Dand, Philip E. Stuart, John Bowes,	2023	29
Prevalence of Advanced Liver Fibrosis in Patients With Severe Psoriasis Catriona Maybury, Heather F. Porter, Ewa Kloczko, JAMA Dermatology	2019	27
Using Real‐World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study Shan Pan, Teresa Tsakok, Nick Dand, Clinical and Translational Science	2020	20

Page 1